Findings

What do systematic reviews say?

24 questions · 24 findings · 3 reviews · Skin

Sort:Best matchNewest Highest certainty Download CSV

No studies found 5 · 20.8%GRADE not reported 0 · 0%Very low 0 · 0%Low 16 · 66.7%Moderate 3 · 12.5%High 0 · 0%

Cetirizine 0.5 mg/kg/d vs placebo (18‐month intervention)

Physician‐assessed changes in clinical signs · children with eczema

1 finding from 1 review

Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 795 participants
Moderate

Cetirizine 0.5 mg/kg/d vs placebo (18‐month intervention)

Secondary outcome: quality of life · children with eczema

The review found no eligible studies for this question.

1 finding from 1 review

Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cetirizine 0.5 mg/kg/d vs placebo (18‐month intervention)

Secondary outcome: clinical flare · children with eczema

1 finding from 1 review

Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 795 participants
Moderate

Loratadine 10 mg vs cetirizine (antihistamine)

Complete cessation of urticaria Global assessment of symptom scores · patients with chronic spontaneous urticaria

Loratadine 10 mg showed no clear difference in complete cessation of urticaria Global assessment of symptom scores compared with cetirizine 10 mg (low certainty).

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
RR 1.05 [0.76, 1.43]
2 studies · 103 participants
Low